Trial design for mold-active agents: time to break the mold--aspergillosis in neutropenic adults

Clin Infect Dis. 2007 May 15;44(10):1298-306. doi: 10.1086/514352. Epub 2007 Apr 9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / adverse effects
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects
  • Aspergillosis / blood
  • Aspergillosis / drug therapy*
  • Dose-Response Relationship, Drug
  • Humans
  • Neutropenia / microbiology*
  • Randomized Controlled Trials as Topic / methods*

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B